Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - OTHER FINANCING ACTIVITIES
Other Financing Activities AKBA - Akebia Therapeutics, Inc.
1 K
LAST VALUE
-99.73%
2 YEAR CAGR
-72.60%
5 YEAR CAGR
-67.85%
10 YEAR CAGR